1,692
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Efficacy of antimicrobial lock solutions in preventing catheter-related blood stream infection in haemodialysis patients: a systematic review and meta-analysis of prospective randomised controlled trials

, , , , , , , , & show all
Pages 95-102 | Received 29 Dec 2014, Accepted 17 Nov 2015, Published online: 30 May 2016

References

  • Collins AJ, Foley RN, Gilbertson DT, et al. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S5–S11.10.2215/CJN.05980809
  • Fysaraki M, Samonis G, Valachis A, et al. Incidence, clinical, microbiological features and outcome of bloodstream infections in patients undergoing hemodialysis. Int J Med Sci. 2013;10(12):1632–1638.10.7150/ijms.6710
  • Katneni R, Hedayati SS. Central venous catheter-related bacteremia in chronic hemodialysis patients: epidemiology and evidence-based management. Nat Clin Pract Nephr. 2007;3(5):256–266.10.1038/ncpneph0447
  • Allon M, Depna TA, Radeva M, et al. Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO study. J Am Soc Nephrol. 2003;14(7):1863–1870.10.1097/01.ASN.0000074237.78764.D1
  • Scott RD. The direct medical costs of health-care associated infections in US hospitals and the benefits of prevention. Atlanta, GA; 2009.
  • Aslam S. Effects of antibacterials on biofilm. Am J Infect Control 2008;36(10):S175.e 9–11. doi: 10.1016/j.ajic.2008.10.002.
  • Weber DJ, Rutala WA. Central Line–Associated Bloodstream Infections: Prevention and Management. Infectious Disease Clinics of North America 2011;25:77–102.10.1016/j.idc.2010.11.012
  • Dogra GK, Herson H, Hutchison B, et al. Prevention of Tunneled Hemodialysis Catheter-Related Infections Using Catheter-Restricted Filling with Gentamicin and Citrate: A Randomized Controlled Study. J Am Soc Nephrol. 2002;13:2133–2139.10.1097/01.ASN.0000022890.29656.22
  • McIntyre CW, Hulme LJ, Taal M, et al. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int. 2004;66:801–805.10.1111/j.1523-1755.2004.00806.x
  • Nori US, Manoharan A, Yee J, et al. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis. 2006;48:596–605.10.1053/j.ajkd.2006.06.012
  • Kim SH, Song KI, Chang JW, et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int. 2006;69:161–164.10.1038/sj.ki.5000012
  • Saxena AK, Panhotra BR, Sundaram DS, et al. Tunneled catheters’ outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int. 2006;70:1629–1635.10.1038/sj.ki.5001776
  • Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis. 2003;36(12):1539–1544.10.1086/375234
  • Weijmer MC, van den Dorpel MA, Van de Ven PJ, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol. 2005;16:2769–2777.10.1681/ASN.2004100870
  • Solomon LR, Cheesbrough JS, Ebah L, et al. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. Am J Kidney Dis. 2010;55:1060–1068.10.1053/j.ajkd.2009.11.025
  • Sankey SS, Weissfeld LA, Fine MJ, et al. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat Simul Comput. 1996;25:1031–1056.10.1080/03610919608813357
  • Kirkwood B. Essentials of medical statistics. 2nd ed. Oxford: Blackwell Scientific Publishers Ltd; 1998.
  • Altman DG, Bland MJ. Interaction revisited: the difference between two estimates. BMJ. 2003;326:219.
  • Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.10.2307/2533446
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.10.1136/bmj.315.7109.629
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.10.1136/bmj.327.7414.557
  • Lau J, Ioannidis JP, Terrin N, et al. The case of the misleading funnel plot. BMJ. 2006;333:597–600.10.1136/bmj.333.7568.597
  • Tobias A. Assessing the influence of single study in the meta-analysis estimate. Stata Technical Bulletin. 1999;8(47):15–17.
  • Guyatt GH, Oxman AD, Schünemann HJ, et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64:380–382.10.1016/j.jclinepi.2010.09.011
  • Huguet A, Hayden JA, Stinson J, et al. Judging the quality of evidence in reviews of prognostic factor research: adapting the GRADE framework. Syst Rev. 2013;2:71. doi: 10.1186/2046-4053-2-71.10.1186/2046-4053-2-71
  • Center for reviews and dissemination: systematic review of clinical tests. In systematic reviews. CRD’S guidance for undertaking reviews in health care. York: CRD, Center for Reviews and Dissemination; 2008. p. 109–156.
  • Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. New York, NY: Academic Press; 1988.
  • Pervez A, Ahmed M, Ram S, et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. J Vasc Access. 2002;3:108–113.
  • MacRae JM, Dojcinovic I, Djurdjev O, et al. Citrate 4% versus Heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol. 2008 Mar;3(2):369–374.10.2215/CJN.01760407
  • Al-Hwiesh AK, Abdul-Rahman ISA. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using vancomycin and gentamicin. Saudi J Kidney Dis Transplant. 2007;18:239–247.
  • Campos RP, do Nascimento M, Chula DC, et al. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. J Am Soc Nephrol. 2011 October;22(10):1939–1945.10.1681/ASN.2010121306
  • Davanipur M, Pakfetrat M, Roozbeh J. Cloxacillin as an antibiotic lock solution for prevention of catheter-associated infection. IJKD. 2011;5:328–331.
  • Maki DG, Ash SR, Winger RK, et al. AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Crit Care Med. 2011 April;39(4):613–620.
  • Moran J, Sun S, Khababa I, et al. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance haemodialysis patients. Am J Kidney Dis. 2011;59(1):102–107.
  • Mortazavi M, Alsaeidi S, Sobhani R, et al. Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime. J Res Med Sci. 2011 March;16(3):303–309.
  • Saxena AK, Al-hafiz A, Abu-Oyun B, et al. Cefotaxime-heparin lock prophylaxis against hemodialysis catheter-related sepsis among Staphylococcus aureus nasal carriers. Saudi J Kidney Dis Transpl. 2012;23(4):743–754.10.4103/1319-2442.98154
  • Droste JC, Jeraj HA, MacDonald A, et al. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother. 2003;51:849–855.10.1093/jac/dkg179
  • Fernandez-Gallego J, Martin M, Gutierrez E, et al. Prophylaxis of gentamicin locking of chronic tunneled central venous catheters does not cause bacterial resistance. Nefrologia. 2011;31(3):308–312.
  • Landry DL, Braden GL, Gobeille SL, et al. Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis. Clin J Am Soc Nephrol. 2010;5(10):1799–1804.10.2215/CJN.01270210
  • Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:565–567.
  • Raad I, Chatzinikolaou I, Chaiban G, et al. In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother. 2003;47:3580–3585.10.1128/AAC.47.11.3580-3585.2003
  • Saxena AK, Panhotra BR. Locking hemodialysis catheters with cefotaxime instead of gentamicin to avoid potential ototoxicity. Kidney Int. 2005;67:2505–2506.10.1111/j.1523-1755.2005.00360.x
  • Francisco IL, Mercedes P, Pedro O, et al. Cefotaxime twenty years later; observational study in critically ill patients. Enferm Infecc Microbiol Clin. 2001;19:211–218.
  • Polaschegg HD, Sodemann K. Safety of concentrated trisodium citrate catheter locks. Nephrol Dial Transplant. 2008;23:4075–4075.10.1093/ndt/gfn404
  • Grudzinski L, Quinan P, Kwok S, et al. Sodium citrate 4% locking solution for central venous dialysis catheters: An effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant. 2007;22:471–476.
  • Safdar N, Maki DG. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med. 2002;30(12):2632–2635.10.1097/00003246-200212000-00003
  • Abad CL, Safdar N. Catheter-related blood stream infections. Infectious diseases. Special ed. New York: McMahon Publishing; 2011.
  • Sexton DJ. Vascular access infection in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infec Dis Clin North Am. 2002;15:731–742.
  • Maar KA. Staphylococcus aureus bacteremia in patients undergoing hemodialysis. Semin Dial. 2000;13:23–29.
  • Li Y, Friedman JY, O’Neal BF, et al. Outcomes of Staphylococcus aureus infection in hemodialysis-dependent patients. Clin J Am Soc Nephrol. 2009;4:428–434.10.2215/CJN.03760708
  • Fowler Jr VG, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis. JAMA. 2005;293:3012–3021.10.1001/jama.293.24.3012
  • Gonzalez C, Rubio M, Romero-Vivas J, et al. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infec Dis. 1999;29: 1171–1177.10.1086/313440
  • Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–1322.10.1126/science.284.5418.1318
  • O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002 Aug 9;51(RR-10):1–29.
  • Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infec Dis. 2005 December;41(11):1591–1598.10.1086/497833
  • Allon M. Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope. Am J Kidney Dis. 2008 February;51(2):165–168.10.1053/j.ajkd.2007.12.003
  • Snaterse M, Rüger W, Scholte op Reimer WJM, et al. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75:1–11.10.1016/j.jhin.2009.12.017
  • Yahav D, Rozen-Zvi B, Gafter-Gvili A, et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta‐analysis of randomized, controlled trials. Clin Infec Dis. 2008;47:83–93.10.1086/590517